Testing effectiveness (Phase 2)Ended earlyNCT03591380
What this trial is testing
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
Who this might be right for
Kidney Transplantation
University of Wisconsin, Madison 3